FR20C1063I1 - Derives de quinolines et compositions pharmaceutiques de ces derives - Google Patents
Derives de quinolines et compositions pharmaceutiques de ces derivesInfo
- Publication number
- FR20C1063I1 FR20C1063I1 FR20C1063C FR20C1063C FR20C1063I1 FR 20C1063 I1 FR20C1063 I1 FR 20C1063I1 FR 20C1063 C FR20C1063 C FR 20C1063C FR 20C1063 C FR20C1063 C FR 20C1063C FR 20C1063 I1 FR20C1063 I1 FR 20C1063I1
- Authority
- FR
- France
- Prior art keywords
- derivatives
- pharmaceutical compositions
- quinoline
- quinoline derivatives
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0613158A GB0613158D0 (en) | 2006-06-30 | 2006-06-30 | Organic compounds |
GB0613156A GB0613156D0 (en) | 2006-06-30 | 2006-06-30 | Organic Compounds |
GB0613160A GB0613160D0 (en) | 2006-06-30 | 2006-06-30 | Organic Compounds |
GB0613159A GB0613159D0 (en) | 2006-06-30 | 2006-06-30 | Organic Compounds |
EP06117129A EP1878722A1 (fr) | 2006-07-13 | 2006-07-13 | Dérivés de quinolinone et leur compositions pharmaceutiques |
EP07819899A EP2044025B1 (fr) | 2006-06-30 | 2007-07-02 | Dérivés de quinolines et compositions pharmaceutiques de ces dérivés |
Publications (1)
Publication Number | Publication Date |
---|---|
FR20C1063I1 true FR20C1063I1 (fr) | 2021-01-22 |
Family
ID=38610531
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR20C1054C Active FR20C1054I1 (fr) | 2006-06-30 | 2020-11-12 | Derives de quinolines et compositions pharmaceutiques de ces derives |
FR20C1063C Active FR20C1063I1 (fr) | 2006-06-30 | 2020-12-08 | Derives de quinolines et compositions pharmaceutiques de ces derives |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR20C1054C Active FR20C1054I1 (fr) | 2006-06-30 | 2020-11-12 | Derives de quinolines et compositions pharmaceutiques de ces derives |
Country Status (28)
Country | Link |
---|---|
US (2) | US8198450B2 (fr) |
EP (1) | EP2044025B1 (fr) |
JP (1) | JP5253392B2 (fr) |
KR (1) | KR101402398B1 (fr) |
CN (1) | CN101479245B (fr) |
AU (1) | AU2007264946B2 (fr) |
BR (1) | BRPI0713951B8 (fr) |
CA (1) | CA2654801C (fr) |
CY (3) | CY1113733T1 (fr) |
DK (1) | DK2044025T3 (fr) |
ES (1) | ES2396987T3 (fr) |
FR (2) | FR20C1054I1 (fr) |
HK (1) | HK1127597A1 (fr) |
HR (1) | HRP20121074T1 (fr) |
HU (2) | HUS2000043I1 (fr) |
IL (1) | IL195796A (fr) |
LT (2) | LTC2044025I2 (fr) |
LU (2) | LUC00185I2 (fr) |
MA (1) | MA30540B1 (fr) |
MX (1) | MX2008016542A (fr) |
MY (1) | MY150468A (fr) |
NO (3) | NO341709B1 (fr) |
NZ (1) | NZ573292A (fr) |
PL (1) | PL2044025T3 (fr) |
PT (1) | PT2044025E (fr) |
SI (1) | SI2044025T1 (fr) |
WO (1) | WO2008000839A1 (fr) |
ZA (1) | ZA200809948B (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2298900A1 (fr) | 1996-09-17 | 2011-03-23 | Novartis Vaccines and Diagnostics, Inc. | Compositions et procédés de traitement de maladies intracellulaires |
CA2697495C (fr) * | 2007-09-05 | 2013-02-05 | Pfizer Limited | Xinafoate de n4-[(2,2-difluoro-4h-benzo[1,4 oxazin-3-one)6-yl]-5-fluoro-n2-[3-(methylaminocarbonylmethyleneoxy)phenyl]pyrimidine-2,4-diamine |
JOP20120023B1 (ar) | 2011-02-04 | 2022-03-14 | Novartis Ag | صياغات مساحيق جافة من جسيمات تحتوي على واحد أو اثنين من المواد الفعالة لعلاج امراض ممرات الهواء الانسدادية او الالتهابية |
WO2014141069A1 (fr) | 2013-03-14 | 2014-09-18 | Novartis Ag | Désamorphisation de formulations séchées par pulvérisation par l'intermédiaire d'un mélange par pulvérisation |
US9452139B2 (en) | 2013-03-14 | 2016-09-27 | Novartis Ag | Respirable agglomerates of porous carrier particles and micronized drug |
ES2747905T3 (es) | 2015-09-29 | 2020-03-12 | Inke Sa | Solvato mixto de L-tartrato de (R)-5-[2-(5,6-dietilindan-2-ilamino)-1-hidroxietil]-8-hidroxi-1H-quinolin-2-ona |
CN110724095B (zh) * | 2019-09-12 | 2023-06-09 | 上海方予健康医药科技有限公司 | 一种茚达特罗乙酸盐的制备方法 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05202301A (ja) * | 1991-08-29 | 1993-08-10 | Yamamoto Chem Inc | 2−アニリノ−3−メチル−6−(N−n−ブチル−N−シクロヘキシルアミノ)フルオランの結晶変態、その製造方法及びこの結晶変態を含有する記録材料 |
EP0688871A3 (fr) * | 1994-06-24 | 1998-07-08 | Quest International B.V. | Préparation de dérivés de la phytosphingosine |
FR2777279B1 (fr) * | 1998-04-08 | 2004-08-13 | Hoechst Marion Roussel Inc | Nouvelles formes cristallines du 1s-[1alpha(2s*,3r*), 9 alpha] 6,10-dioxo-n-(2-ethoxy-5-oxo-tetrahydro-3-furanyl) -9[[(1-isoquinolyl)carbonyl]amino]octohydro-6h-pyridazino [1,2-a][1,2]diazepine-1-carboxamide |
GB9913083D0 (en) | 1999-06-04 | 1999-08-04 | Novartis Ag | Organic compounds |
GB0029562D0 (en) * | 2000-12-04 | 2001-01-17 | Novartis Ag | Organic compounds |
GB0103926D0 (en) | 2001-02-17 | 2001-04-04 | Astrazeneca Ab | Chemical compounds |
GB0127430D0 (en) | 2001-11-15 | 2002-01-09 | Smithkline Beecham Corp | Compounds |
US7417051B2 (en) * | 2002-04-12 | 2008-08-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising betamimetics and a novel anticholinergic |
US7250426B2 (en) * | 2002-11-29 | 2007-07-31 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Tiotropium-containing pharmaceutical combination for inhalation |
GB0303910D0 (en) | 2003-02-20 | 2003-03-26 | Merck Sharp & Dohme | Therapeutic agents |
TWI324150B (en) | 2003-02-28 | 2010-05-01 | Novartis Ag | Process for preparing 5-[(r)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-(1h)-quinolin-2-one salt |
PE20100399A1 (es) | 2003-04-02 | 2010-06-01 | Novartis Ag | Procedimiento para preparar oxi-(1h)-quinolin-2-onas 5-(alfa-haloacetil)-8-sustituidas |
ATE421322T1 (de) | 2003-04-04 | 2009-02-15 | Novartis Pharma Gmbh | Chinolin-2-on-derivate zur behandlung von erkankungen der atemwege |
JP2005343889A (ja) | 2004-05-06 | 2005-12-15 | Taisho Pharmaceut Co Ltd | イミダゾピリジン誘導体 |
GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
GB0413960D0 (en) | 2004-06-22 | 2004-07-28 | Novartis Ag | Organic compounds |
PT1869049E (pt) | 2005-03-21 | 2009-05-26 | Lilly Co Eli | Compostos de imidazopiridazina |
GB0511065D0 (en) | 2005-05-31 | 2005-07-06 | Novartis Ag | Organic compounds |
WO2007013673A1 (fr) | 2005-07-29 | 2007-02-01 | Astellas Pharma Inc. | Hétérocycles fusionnés en tant qu’inhibiteurs de lck |
-
2007
- 2007-07-02 BR BRPI0713951A patent/BRPI0713951B8/pt active IP Right Grant
- 2007-07-02 DK DK07819899.1T patent/DK2044025T3/da active
- 2007-07-02 US US12/304,617 patent/US8198450B2/en active Active
- 2007-07-02 CA CA2654801A patent/CA2654801C/fr active Active
- 2007-07-02 SI SI200731103T patent/SI2044025T1/sl unknown
- 2007-07-02 KR KR1020087031819A patent/KR101402398B1/ko active IP Right Grant
- 2007-07-02 NZ NZ573292A patent/NZ573292A/en unknown
- 2007-07-02 JP JP2009517241A patent/JP5253392B2/ja active Active
- 2007-07-02 PL PL07819899T patent/PL2044025T3/pl unknown
- 2007-07-02 ES ES07819899T patent/ES2396987T3/es active Active
- 2007-07-02 MY MYPI20085146 patent/MY150468A/en unknown
- 2007-07-02 CN CN2007800244042A patent/CN101479245B/zh active Active
- 2007-07-02 PT PT78198991T patent/PT2044025E/pt unknown
- 2007-07-02 WO PCT/EP2007/056632 patent/WO2008000839A1/fr active Application Filing
- 2007-07-02 EP EP07819899A patent/EP2044025B1/fr active Active
- 2007-07-02 AU AU2007264946A patent/AU2007264946B2/en active Active
- 2007-07-02 MX MX2008016542A patent/MX2008016542A/es active IP Right Grant
-
2008
- 2008-11-24 ZA ZA2008/09948A patent/ZA200809948B/en unknown
- 2008-12-08 IL IL195796A patent/IL195796A/en active IP Right Grant
- 2008-12-30 MA MA31527A patent/MA30540B1/fr unknown
-
2009
- 2009-01-20 NO NO20090312A patent/NO341709B1/no active Protection Beyond IP Right Term
- 2009-07-20 HK HK09106611.7A patent/HK1127597A1/xx unknown
-
2012
- 2012-05-04 US US13/463,978 patent/US20120316142A1/en not_active Abandoned
- 2012-11-29 CY CY20121101169T patent/CY1113733T1/el unknown
- 2012-12-28 HR HRP20121074TT patent/HRP20121074T1/hr unknown
-
2020
- 2020-11-12 FR FR20C1054C patent/FR20C1054I1/fr active Active
- 2020-11-18 HU HUS2000043C patent/HUS2000043I1/hu unknown
- 2020-11-20 LU LU00185C patent/LUC00185I2/fr unknown
- 2020-11-23 NO NO2020041C patent/NO2020041I1/no unknown
- 2020-11-25 LT LTPA2020535C patent/LTC2044025I2/lt unknown
- 2020-11-26 CY CY2020038C patent/CY2020038I2/el unknown
- 2020-12-07 LU LU00188C patent/LUC00188I2/en unknown
- 2020-12-07 NO NO2020044C patent/NO2020044I1/no unknown
- 2020-12-08 FR FR20C1063C patent/FR20C1063I1/fr active Active
- 2020-12-09 HU HUS2000053C patent/HUS2000053I1/hu unknown
- 2020-12-14 CY CY2020041C patent/CY2020041I1/el unknown
- 2020-12-16 LT LTPA2020538C patent/LTPA2020538I1/lt unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR20C1063I1 (fr) | Derives de quinolines et compositions pharmaceutiques de ces derives | |
IL199853A (en) | Converged history of 5-Hydroxy-Admentil-2-Reindeer and Pharmaceutical Preparation containing them | |
BRPI0918206A2 (pt) | derivados de animoéster e composição medicinal destes | |
BRPI0923836A2 (pt) | Composições farmacêuticas orais contendo opióide e métodos | |
BRPI0906980A2 (pt) | Composição de derivados e maleatados | |
SMT201700084B (it) | Associazioni antineoplastiche di 4-anilino-3-cianochinoline e capecitabina | |
DE602007010981D1 (de) | Cycloalkylaminsubstituierte isochinolin- und isochinolinonderivate | |
CR10815A (es) | Nuevos derivados de isoquinolina e isoquinolinona sustituidos | |
DOP2007000084A (es) | Derivados de dihidropirazolopirimidinona | |
EP2188259A4 (fr) | Procédé de fabrication et d'administration de dérivés de quinoléine en tant qu'agents anticancéreux | |
IL206594A (en) | The history of azinone-tetrahydropyridoindole and its containing pharmaceutical preparations | |
CR10229A (es) | Derivados de 1,2,4,5,-tetrahidro-3h-benzazepinas, su procedimiento de preparación y las composiciones farmacéuticas que las contienen | |
BRPI1007092A2 (pt) | "derivados de hidroxamato, uso dos derivados de hidroxamato, composições farmacêuticas, método para prevenção ou tratamento de doença e método de produção de derivados de hidroxamato" | |
IL193211A (en) | Derivatives of Indzol-Troaril and pharmaceutical preparations containing them | |
BRPI0813100A2 (pt) | Preparação sólida farmacêutica e método de produção da mesma | |
CR10809A (es) | Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona | |
ATE499368T1 (de) | Chinolonverbindung und pharmazeutische zusammensetzung | |
BRPI0922286A2 (pt) | composto de quinolona e composição farmacêutica. | |
BRPI0819202A2 (pt) | Derivado heterocíclico, e, composição farmacêutica | |
UY33128A (es) | Derivados de piridinona y composiciones farmacéuticas de los mismos | |
ZA200806725B (en) | New citrate salt of an indole derivative and its pharmaceutical use | |
ATE465994T1 (de) | Antibakterielle chinolinderivate | |
SI2220047T1 (sl) | Derivati kinolina, farmacevtski sestavki, ki jih vsebujejo in njihova uporaba | |
BRPI0812832A2 (pt) | Combinação farmacêutica de opioides e composto de prostaglandina | |
TH0801002797A (th) | สารประกอบควินอโลน และองค์ประกอบทางเภสัชกรรม |